PDF(Pubmed)
Abstract：
UNASSIGNED: Insulinoma during pregnancy is a rare condition with vague clinical symptoms, making diagnosis challenging. The standard treatment for insulinoma is surgical tumor removal, preferably using a minimally invasive method. However, there have been no recorded examples of employing a robotic platform in pregnant women with insulinoma. In this report, we present the first successful case of robotic enucleation for insulinoma during pregnancy.
UNASSIGNED: A 30-year-old pregnant woman presented with recurrent hypoglycemic symptoms throughout her first trimester that were relieved by food intake. After confirming endogenous hyperinsulinemia, an abdominal magnetic resonance imaging scan was performed to locate the tumor. A well-defined 2-cm mass was found in the pancreatic body. Robotic enucleation was performed at week 18 of gestation, and the patient experienced relief from hypoglycemic episodes postoperatively. Her blood glucose levels returned to normal, and she had an uneventful pregnancy. The patient eventually delivered a healthy baby via cesarean section without any complications.
UNASSIGNED: For a subset of pregnant individuals with insulinoma, a minimally invasive approach as robotic-assisted surgery is safe and feasible. This innovative technique has the potential to both mothers and fetuses.
UNASSIGNED: A 30-year-old pregnant woman presented with recurrent hypoglycemic symptoms throughout her first trimester that were relieved by food intake. After confirming endogenous hyperinsulinemia, an abdominal magnetic resonance imaging scan was performed to locate the tumor. A well-defined 2-cm mass was found in the pancreatic body. Robotic enucleation was performed at week 18 of gestation, and the patient experienced relief from hypoglycemic episodes postoperatively. Her blood glucose levels returned to normal, and she had an uneventful pregnancy. The patient eventually delivered a healthy baby via cesarean section without any complications.
UNASSIGNED: For a subset of pregnant individuals with insulinoma, a minimally invasive approach as robotic-assisted surgery is safe and feasible. This innovative technique has the potential to both mothers and fetuses.
摘要：
■妊娠期胰岛素瘤是一种临床症状模糊的罕见疾病，诊断具有挑战性。胰岛素瘤的标准治疗方法是手术切除肿瘤，优选使用微创方法。然而,没有记录的例子在胰岛素瘤孕妇中使用机器人平台。在这份报告中,我们介绍了妊娠期间胰岛素瘤机器人摘除术的第一个成功案例。
一名30岁的孕妇在她的头三个月出现反复的低血糖症状，这些症状通过食物摄入得到缓解。在确认内源性高胰岛素血症后，进行腹部磁共振成像扫描以定位肿瘤.在胰腺体内发现了一个定义明确的2厘米肿块。在妊娠第18周进行机器人摘除，患者术后出现低血糖发作缓解。她的血糖水平恢复正常,她怀孕顺利.患者最终通过剖宫产分娩了一个健康的婴儿，没有任何并发症。
■对于一部分患有胰岛素瘤的孕妇，作为机器人辅助手术的微创方法是安全可行的.这种创新技术对母亲和胎儿都有潜力。
一名30岁的孕妇在她的头三个月出现反复的低血糖症状，这些症状通过食物摄入得到缓解。在确认内源性高胰岛素血症后，进行腹部磁共振成像扫描以定位肿瘤.在胰腺体内发现了一个定义明确的2厘米肿块。在妊娠第18周进行机器人摘除，患者术后出现低血糖发作缓解。她的血糖水平恢复正常,她怀孕顺利.患者最终通过剖宫产分娩了一个健康的婴儿，没有任何并发症。
■对于一部分患有胰岛素瘤的孕妇，作为机器人辅助手术的微创方法是安全可行的.这种创新技术对母亲和胎儿都有潜力。
